I think Neuren Pharmaceuticals could be the cheapest biotech in Australia for the following reasons.
1.Company is currently capitalized at $120 million.
2 .It is fully funded with money in the bank and another $10 million coming from Lanstead Capital .
3.The company has been granted a Type B meeting with the FDA in October .(so about a month to go before their guidance )
4.The retts syndrome association in the USA is now a shareholder .
5.The drug trofinetide worked better the longer the trial went .
6.Steve Kaminsky Chief scientist of Rettsyndrome.org said and I will quote .These paediatric results are very exciting .The data suggest that trofinetide is having a positive change on a number of challenge of Rett syndrome .We at Rettsyndrome.org are very proud to have supported this game changing study ,believing that the best is yet to come.
7.As well as Rett syndrome the drug should work on Fragile x and other autism issues .
Is Neuren the cheapest biotech stock in Australia .
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1060 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.87 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |